Verona Pharma has seen its stock price jump by 125 percent year-to-date, closing at $104.74 versus $46.44 in the last trading ...

The rally came despite a broader market volatility during the period, largely due to global trade worries over the United States’ imposition of tariffs against its trading partners, with China ...

The transaction will enhance Merck's cardio-pulmonary pipeline and portfolio with the addition of Ohtuvayre, an FDA-approved COPD treatment.

Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease.

Explore safer cannabis options for asthma patients. Learn how CBD, CBG, and non-inhalation methods can support respiratory health without smoke.

If you have (COPD), your doctor may prescribe inhaled corticosteroids as part of your treatment. Learn how to take them, how they can help, what the side effects might be.

Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization ...

We consulted doctors to learn more about cortisol imbalance symptoms, causes and treatment.